BHV Partners has been granted €200,000 in a participatory loan from the Spanish National Innovation Company (Enisa) to consolidate its organisational structure and continue to project its international growth.
BHV was created in 2019 and has two lines of business: venture builder and consultancy for technology transfer and innovation institutions, start-ups, and the biomedical industry.
“Enisa’s financial support endorses our business model’s viability” says Albert G. Zamora, Co-Founder and chairman of the Board of BHV. “Also consolidates us as an innovative player in the biomedical ecosystem that is positioning itself in a differentiated and complementary way to traditional accelerators, incubators and venture capital” explains Dr Marta Príncep, Co-Founder and CEO of BHV.
As a venture builder, BHV chooses projects that are innovative and helps them grow by investing in them at the beginning and working with them throughout their life cycle. This includes having specialised strategic knowledge and managing operations, which helps these start-ups open the doors to seed, Series A, and Series B rounds of investment. BHV currently has seven investee start-ups and two more in the process of creation during the fourth quarter of 2022. The objective is to generate a portfolio of 30 start-ups with a balanced risk-opportunity ratio, combining different sub-sectors (therapies, medical devices, digital health, IVD and nutrition). Moreover, the portfolio of clients in consulting services is increasing significantly.
BHV has an international network of 60 partners and senior experts, primarily based in Spain, the United States, Denmark, Israel, and Switzerland. “We are a talent pool of serial entrepreneurs, C-Level executives, investors, doctors and scientists to advise and mentor our investee start-ups”, says Marta Príncep. In addition to this network, BHV carries out its activity with a professional team that will be strengthened during 2023 thanks to Enisa’s loan.
Last July, BHV closed a second round of investment of €500,000 with the participation of current and new partners such as business angels, entrepreneurs, managers, and scientists in the sector.